The highly selective cyclo-oxygenase 2 inhibitor rofecoxib demonstrates anti-tumour effects in Lewis lung cancer cell line and anti-angiogenic effects in vitro
Keyword(s):
2012 ◽
Vol 13
(3)
◽
pp. 761-766
◽
Keyword(s):
Keyword(s):
2006 ◽
Vol 32
(9)
◽
pp. 441-453
◽
Keyword(s):
2013 ◽
Vol 9
(8)
◽
pp. 1073-1084
◽
Keyword(s):
2007 ◽
Vol 31
(5)
◽
pp. 500-507
◽
Keyword(s):
2008 ◽
Vol 3
(10)
◽
pp. 1934578X0800301
◽
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 187
(4)
◽
pp. 1328-1343
◽
Keyword(s):
1998 ◽
Vol 41
(5)
◽
pp. 1171-1176
◽
Keyword(s):